In June 2023, the Polynucleotide distributor, Amedica announced the rebranding of its Nucleadyn injectable polymerised polynucleotide range to Ameela. The only difference between Nucleadyn and Ameela is the name. Nothing else about the treatment has changed, with all product formulations, indications, and the portfolio of case studies and clinical data staying the same.